Related Experiment Video
Updated: Jun 25, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
[Surgery for aortic valve endocarditis]
1Division of Cardiovascular Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
Insights
Early diagnosis of infective endocarditis is vital. A new cardiopulmonary bypass strategy using nafamostat mesilate shows promise in preventing brain hemorrhage complications during surgery for aortic valve endocarditis.
Area of Science:
- Cardiology
- Infectious Diseases
- Cardiac Surgery
Context:
- Infective endocarditis (IE) is a severe infection requiring prompt diagnosis via Duke's criteria, blood cultures, and echocardiography.
- IE often leads to intracardiac and extracardiac complications, frequently necessitating surgical intervention.
- Managing IE with concurrent brain complications presents challenges, particularly regarding anticoagulation during cardiopulmonary bypass (CPB).
Purpose:
- To evaluate a novel CPB strategy using nafamostat mesilate as an anticoagulant for patients with recent intracranial hemorrhage undergoing surgery for IE.
- To assess the safety and efficacy of aortic root replacement in patients with destructive aortic valve endocarditis causing left ventricular-aortic discontinuity.
Summary:
- A novel CPB strategy with nafamostat mesilate demonstrated potential safety in preventing the deterioration of recent intracranial hemorrhage.
- Nine patients with left ventricular-aortic discontinuity due to destructive aortic valve endocarditis underwent aortic root replacement using pulmonary autografts or xenografts.
- Radical debridement of aortic root abscesses was performed in all cases.
Impact:
- The novel CPB strategy may offer a safer anticoagulation option for IE patients with intracranial hemorrhage.
- Aortic root replacement procedures for severe aortic valve endocarditis resulted in no in-hospital mortality.
- Patients undergoing aortic root replacement achieved 67% freedom from major adverse cardiac events at 5 years, indicating favorable long-term outcomes.
Abstract:
Infective endocarditis is a life-threatening disease that should be diagnosed based on Duke's criteria as early as possible. A positive blood culture and echocardiographic findings, particularly those of a transesophageal echocardiogram, play a pivotal role in the process of confirming a diagnosis. Medical treatment using appropriate antibiotics against the identified microorganism is of primary importance, although infective endocarditis is often accompanied by intracardiac or extracardiac complications and must be converted to surgery. The timing of surgery for patients with brain complications is crucial but still controversial because the usage of heparin for cardiopulmonary bypass (CPB) may cause the complications to deteriorate. We demonstrated that a novel CPB strategy with nafamostat mesilate as an anticoagulant may be potentially safe and useful in preventing deterioration of recent intracranial hemorrhage. Destructive aortic valve endocarditis causes the development of left ventricular-aortic discontinuity. In the past 8 years, 9 patients with left ventricular-aortic discontinuity underwent aortic root replacement in our institution. Radical debridement of the aortic root abscess was performed in all cases, followed by aortic root replacement with a pulmonary autograft (Ross procedure) or a stentless aortic root xenograft. No mortality was observed during hospitalization and follow-up. Freedom from major adverse cardiac events was noted in 67% of the patients at 5 years.
More Related Videos
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Endocarditis IV: Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis

